Razi Ingber
Net worth: 5 M $ as of 30/09/2026
Net worth: 5 M $ as of 30/09/2026
Razi Ingber currently works at RedHill Biopharma Ltd., as Chief Financial Officer from 2023.
Mr. Ingber also formerly worked at PricewaterhouseCoopers (Israel), as Audit Manager.
Mr. Ingber received his undergraduate degree and graduate degree from Tel-Aviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/04/2026 | 109,680,000 ( 0.21% ) | 5 M $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Director of Finance/CFO | 01/05/2023 |
| Companies | Position | End |
|---|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions